MYH6 and breast carcinoma: Research on breast cancer cell lines indicates an inhibitory effect of 17β-estradiol, BPA and other known endocrine disruptor compounds; genistein and polychlorinated biphenyl congener 54 (PCB54), on the Myh6 transcript levels [41].